Newsroom | 5113 results
Sorted by: Latest
-
Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada
HYDERABAD, India & MISSISSAUGA, Ontario--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. announced that it has received a Notice of Compliance (NOC) from Health Canada for its generic Semaglutide Injection....
-
MedImpact Expands MedEmpower Fuel™ With Women’s Health Program
SAN DIEGO--(BUSINESS WIRE)--MedImpact, the nation’s largest independent pharmacy benefit and health solutions company, today announced the expansion of its MedEmpower Fuel™ platform with the launch of a comprehensive Women’s Health Program–further advancing its commitment to proactive, personalized, and whole-person care. This expansion reflects MedImpact’s continued investment in solutions that go beyond traditional pharmacy benefits–addressing the evolving needs of members while delivering be...
-
CorVista Health Announces Collaboration with Mayo Clinic to Advance Next-Gen Pulmonary Hypertension Diagnosis
BETHESDA, Md.--(BUSINESS WIRE)--CorVista Health has announced a research collaboration with Mayo Clinic to evaluate how next-generation, non-invasive diagnostics may transform the identification and management of pulmonary hypertension (PH) – a complex and frequently underdiagnosed cardiovascular condition that affects an estimated one percent of the global population. Pulmonary hypertension is a progressive and potentially life-threatening condition characterized by elevated pressure in the pu...
-
Ashvattha Therapeutics Announces Presentations Highlighting Mechanism of Action for Migaldendranib in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Ashvattha Therapeutics ("Ashvattha"), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier in areas of inflammation selectively targeting activated cells in the retina, announced presentations at the Association for Research in Vision and Ophthalmology (ARVO) highlighting the clinical trial results of migaldendranib (MGB) for the treatment of diabetic macular edema (DME) and neovascular age-related macular...
-
Insulet to Participate in BofA Securities 2026 Health Care Conference
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the BofA Securities 2026 Health Care Conference in Las Vegas on Wednesday, May 13, 2026 at 9:20 a.m. (Pacific Time). The live webcast and replay of the presentation will be accessible on the Insulet Investor Relations website: investors.insulet.com/events. About Insulet Corporation: Insulet C...
-
Tandem Diabetes Care’s Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes
SAN DIEGO--(BUSINESS WIRE)--FDA clears Tandem Diabetes Care's Control-IQ+ automated insulin delivery technology for use in pregnancy for people with type 1 diabetes....
-
Genentech Partners With Comedy Icon Damon Wayans and diaTribe to Address Diabetes-Related Vision Loss With ‘All Eyes on DME’ Campaign
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced the launch of All Eyes on DME, a campaign developed in partnership with advocacy group, diaTribe, that harnesses the power of humor to destigmatize and bring attention to diabetes-related vision conditions. The multi-channel campaign features Damon Wayans’ iconic humor and personal diabetes journey, as well as patient perspectives to create a powerful cultural connection...
-
New EndoTool IV Data Presented at AACE Show Virtual Elimination of Severe Hypoglycemia Across 19 Hospitals
PALO ALTO, Calif. & LAS VEGAS--(BUSINESS WIRE)--Glooko, Inc., a globally integrated digital healthcare company focused on helping healthcare systems solve the growing challenges of glycemic safety and diabetes management across care settings, today announced data presented at the American Association of Clinical Endocrinology (AACE) Annual Meeting. The evidence, reflecting outcomes from a three-year retrospective analysis spanning from January 2023 through December 2025, demonstrated that EndoT...
-
Outcome Capital Further Bolsters Its Platform with the Addition of Jaison Ellis
BOSTON--(BUSINESS WIRE)--Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that Jaison Ellis has joined the firm as a Managing Director, based in Charlotte, NC. The firm continues to expand its life sciences and healthcare practices through its unique, market-aligned, strategy-driven platform, delivering mergers and acquisitions, partnerships, and strategic advisory services. “I’m delighted to join such a distinguished...
-
Welldoc Brings AI-Powered Cardiometabolic Care to 68 Million Medicare Beneficiaries Through the ACCESS Model and Medicare App Library
COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced it has been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model. Welldoc will participate in both the Cardio-Kidney-Metabolic (CKM) and Early CKM (eCKM) tracks, bringing its AI-driven clinical platform to Medicare beneficiaries living with diabetes, obesity, hypertension, a...